Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Can photobiomodulation therapy be an alternative to pharmacological therapies in decreasing the progression of skeletal muscle impairments ofmdxmice?

Full text
Author(s):
Show less -
Tomazoni, Shaiane Silva [1] ; Casalechi, Heliodora Leao [2] ; Bacelar Ferreira, Cheila de Sousa [2] ; Serra, Andrey Jorge [3] ; Delle, Humberto [4] ; de Oliveira Brito, Rodrigo Barbosa [4] ; de Melo, Brunno Lemes [3] ; Vanin, Adriane Aver [5, 2] ; Ribeiro, Neide Firmo [5, 2] ; Pereira, Amanda Lima [2] ; Damasceno Soares Monteiro, Kadma Karenina [5, 2] ; Marcos, Rodrigo Labat [6] ; Camillo de Carvalho, Paulo de Tarso [5] ; Frigo, Lucio [2, 7] ; Pinto Leal-Junior, Ernesto Cesar [5, 1, 2]
Total Authors: 15
Affiliation:
[1] Univ Bergen, Dept Global Publ Hlth & Primary Care, Physiotherapy Res Grp, Bergen - Norway
[2] Univ Nove Julho UNINOVE, Lab Phototherapy & Innovat Technol Hlth LaPIT, Sao Paulo, SP - Brazil
[3] Univ Fed Sao Paulo UNIFESP, Postgrad Program Med, Sao Paulo, SP - Brazil
[4] Univ Nove Julho UNINOVE, Postgrad Program Med, Sao Paulo, SP - Brazil
[5] Univ Nove Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP - Brazil
[6] Univ Nove Julho UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, SP - Brazil
[7] Univ Guarulhos UnG, Dept Periodontol, Dent Res Div, Guarulhos, SP - Brazil
Total Affiliations: 7
Document type: Journal article
Source: PLoS One; v. 15, n. 8 AUG 12 2020.
Web of Science Citations: 0
Abstract

Objective To compare the effects of photobiomodulation therapy (PBMT) and pharmacological therapy (glucocorticoids and non-steroidal anti-inflammatory drugs) applied alone and in different combinations inmdxmice. Methods The animals were randomized and divided into seven experimental groups treated with placebo, PBMT, prednisone, non-steroidal anti-inflammatory drug (NSAIDs), PBMT plus prednisone and PBMT plus NSAID. Wild type animals were used as control. All treatments were performed during 14 consecutive weeks. Muscular morphology, protein expression of dystrophin and functional performance were assessed at the end of the last treatment. Results Both treatments with prednisone and PBMT applied alone or combined, were effective in preserving muscular morphology. In addition, the treatments with PBMT (p = 0.0005), PBMT plus prednisone (p = 0.0048) and PBMT plus NSAID (p = 0.0021) increased dystrophin gene expression compared to placebo-control group. However, in the functional performance the PBMT presented better results compared to glucocorticoids (p<0.0001). In contrast, the use of NSAIDs did not appear to add benefits to skeletal muscle tissue inmdxmice. Conclusion We believe that the promising and optimistic results about the PBMT in skeletal muscle ofmdxmice may in the future contribute to this therapy to be considered a safe alternative for patients with Duchenne Muscular Dystrophy (DMD) in a washout period (between treatment periods with glucocorticoids), allowing them to remain receiving effective and safe treatment in this period, avoiding at this way periods without administration of any treatment. (AU)

FAPESP's process: 15/21012-2 - Effects of photobiomodulation therapy and pharmacological therapy at isolated and associated manner in experimental model of Duchenne Muscular Dystrophy
Grantee:Lúcio Frigo
Support type: Regular Research Grants